Search

everythinglearnresearchcommunity

for

Search:↓

Different drugs for prostate-related urinary symptoms work but have various side effects, and treatment should be tailored to the individual.

Type I interferons play a key role in the development of various skin diseases.

Hair loss from genetics and hormones can be treated with drugs or surgery.

EF and PXE not closely related.

Scientists found genes linked to the growth of high-quality brush hair in Chinese Haimen goats.

The conclusion is that a new test was created to find substances that affect specific ion channels, and it works well for drug discovery.

New treatments targeting T-cell pathways are needed for better alopecia areata management.

Men with thinner hair from genetic hair loss may be more likely to have an enlarged prostate.

Dutasteride is more effective than finasteride for hair loss, but more research is needed on safety and dosing.

The new topical product combined with finasteride significantly increased hair thickness without side effects.

Dutasteride is approved to help manage prostate enlargement.

Dutasteride effectively treats benign prostatic obstruction, improves urinary flow, reduces prostate size, and may prevent prostate cancer, but can cause sexual side effects.

PrEP doesn't increase STI risk in high-risk men, anti-androgen drugs may lower ICU admission for male COVID-19 patients, a 3-point injection is better for crow's feet, and the 'Geriatric-8' tool could help assess frailty in older skin cancer patients.

A Korean woman with complete hair loss regrew her hair after taking tofacitinib, with no side effects.

Psoriasis patients are more likely to develop alopecia areata due to complex autoimmune interactions.

The document concludes that better targeted treatments are needed for wound healing, and single-cell technologies may improve cell-based therapies.

Metformin helps with menstrual cycles and insulin levels in PCOS but is less effective for hair growth, diabetes prevention, and weight loss, and may improve fertility and reduce diabetes risk.

Ruxolitinib effectively regrows hair in most patients with severe hair loss.

Removing both Atr and Trp53 genes in adult mice causes severe tissue damage and death due to DNA damage.

Ritlecitinib is approved in the USA and Japan for treating severe hair loss in people aged 12 and older.

The document suggests that targeting the hormone DHT could be a more effective treatment for prostate cancer than targeting testosterone.

Possible new treatments for common hair loss include drugs, stem cells, and improved transplants.

A new mutation in the STING protein causes a range of symptoms and its severity may be affected by other genetic variations; treatment with a specific inhibitor showed improvement in one patient.

Dutasteride effectively treats enlarged prostate, reduces prostate cancer risk, and promotes hair regrowth with few side effects.

Tofacitinib temporarily regrew hair in a man with alopecia, but its effects didn't last.

The document concludes that there are various treatments for different types of alopecia, but more research is needed for evidence-based treatments.

Androgen Deprivation Therapy for prostate cancer often reduces sexual function but intermittent therapy may be more tolerable.

Regenerative therapies show promise for treating vitiligo and alopecia areata.

PCOS may start before birth, involves metabolic issues, and can be treated with drugs like metformin and lifestyle changes.

Certain herbal compounds, especially from bitter melon, can inhibit cancer growth and promote hair growth by blocking PAK1.